摘要：

我国国民经济和社会发展第十二个五年规划（简称“十二五”）时期，脑血管病临床研究取得重大进展，高危非致残性脑血管事件的抗血小板治疗、规范化缺血性卒中二级预防、社区无症状性缺血性卒中流行病学调查、中药治疗缺血性卒中横断面研究、血糖对急性缺血性卒中预后的影响、缺血性卒中合并慢性肾脏病和脑微出血、缺血性脑血管病生物学标志物、线粒体脑肌病伴高乳酸血症和卒中样发作与脑萎缩、脑出血围术期血压管理、预测血管结构异常性脑出血预后量表、脑血管病流行病学调查等项研究成果分别发表于国内外重要期刊，本文拟对上述研究进展进行简要综述。

关键词: 脑血管障碍, 中国, 综述

Abstract:

During the period of Twelfth Five-Year Plan for National Economic and Social Development, clinical study on cerebrovascular disease in China has made great progress. The results of antiplatelet treatment in patients with high-risk non-disabling cerebrovascular events, standardized secondary prevention of ischemic stroke, epidemiological survey of asymptomatic ischemic stroke in community population, cross-sectional survey on traditional Chinese medicine for treating ischemic stroke, the impact of blood glucose on prognosis of acute ischemic stroke, ischemic stroke combined with chronic kidney disease and cerebral microbleeds, biomarkers of ischemic cerebrovascular diseases, mitochondrial encephalomyopathy with lactic academia and stroke-like episodes (MELAS) and encephalatrophy, perioperative management of blood pressure in intracerebral hemorrhage, vascular structural abnormality-related intracerebral hemorrhage score (VSARICHS), and epidemiological survey of cerebrovascular disease in China have been published in many important journals. This paper reviewed these studies and made a brief introduction.

Key words: Cerebrovascular disorders, China, Review